PMV PHARMACEUTICALS INC
PMVP · NASDAQ
Updated at 2026-10-13 15:06:24
- Today's High
- $1.46
- Today’s Low
- $1.37
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.55
- Previous Close
- $1.41
- Volume
- 398.62K
- Market Cap
- $106.47M
- P/E Ratio
- --
- EPS
- $-1.41
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 400 ALEXANDER PARK DRIVE, PRINCETON, NJ, UNITED STATES, 08540
- Country
- US
- Listing Date
- 2020-09-25
- Fiscal Year End
- December
- Shares Outstanding
- 53.33M
- CIK
- 0001699382
- Website
- www.pmvpharma.com
PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53 mutations in cancer. The company is headquartered in Cranbury, New Jersey.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$18.88M
2026-03-31
$18.98M
2025-12-31
$19.24M
2025-09-30
$22.52M
Net Income
2026-06-30
-$18.08M
2026-03-31
-$18.03M
2025-12-31
-$18.03M
2025-09-30
-$21.05M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.34
2026-03-31
$-0.34
2025-12-31
$-0.34
2025-09-30
$-0.40
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$18.86M
2026-03-31
-$18M
2025-12-31
-$17.97M
2025-09-30
-$21.03M
Effective Tax Rate
2026-06-30
-0.01%
2026-03-31
--
2025-12-31
-0.14%
2025-09-30
0.02%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $18.88M | $18.98M | $19.24M | $22.52M |
| Net Income | -$18.08M | -$18.03M | -$18.03M | -$21.05M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.34 | $-0.34 | $-0.34 | $-0.40 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$18.86M | -$18M | -$17.97M | -$21.03M |
| Effective Tax Rate | -0.01% | -- | -0.14% | 0.02% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.